Cite

HARVARD Citation

    Karunaratne, K. et al. (2021). Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis. BMJ neurology open. 3 (1), p. . [Online]. 
  
Back to record